Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
September 24, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Transgene prévoit d’importants résultats cliniques d’ici fin 2024 et confirme sa visibilité financière jusqu’au 4ème trimestre 2025
September 24, 2024 11:45 ET
|
Transgene S.A.
Résultats financiers du 1er semestre 2024 et point sur l’activité Produit phare TG4050 (vaccin thérapeutique individualisé) : - Premiers signes de bénéfice clinique dans le cancer...
Transgene to Report Major Clinical Data before the end of 2024 – Confirmed Financial Visibility until Q4 2025
September 24, 2024 11:45 ET
|
Transgene S.A.
2024 Half-Year Results and Business Update Lead program TG4050 (individualized immunotherapy): – First signs of clinical benefit in adjuvant head and neck cancer reported at AACR 2024,...
Cancer Supportive Care Product Market is Set to Surge at 6.9% CAGR, to Reach US$ 68.93 Billion by 2034 | Fact.MR
September 24, 2024 06:00 ET
|
FACT.MR
Rockville, MD, Sept. 24, 2024 (GLOBE NEWSWIRE) -- In its new study, Fact.MR states that the global cancer supportive care product market is estimated to reach a value of US$ 35.47 billion in 2024...
Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership with eXmoor pharma
September 24, 2024 05:30 ET
|
Quell TX
Multi-year agreement focuses on the manufacture of multiple CAR-Treg product candidates for Phase 1/2 clinical studies Partnership builds on long-term relationship to provide Quell with additional...
Climate Tech VC Cerulean Ventures Closes Fund I at Climate Week NYC 2024
September 23, 2024 08:18 ET
|
Cerulean Ventures, LLC
Cerulean Ventures, a climate tech VC firm, has closed a $10M pre-seed fund at Climate Week NYC 2024, focused on software for hard problems in climate.
LifeSci Advisors Appoints Lindsey Trickett to its Investor Relations Team
September 23, 2024 08:00 ET
|
LifeSci Advisors, LLC
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- LifeSci Advisors, an investor relations and corporate communications firm focused on the healthcare sector, today announces the appointment of Lindsey...
Global Corporate Wellness Market to Surpass ~USD 117 Billion by 2030 | DelveInsight
September 23, 2024 06:30 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Global Corporate Wellness Market to Surpass ~USD 117 Billion by 2030 | DelveInsight The growing demand for corporate wellness is largely driven...
Squamous Cell Carcinoma Clinical Trial Pipeline Insights: 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | DelveInsight
September 20, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Squamous Cell Carcinoma Clinical Trial Pipeline Insights: 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space |...
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
September 20, 2024 08:30 ET
|
Fortress Biotech, Inc.
MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to...